We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00983658
Recruitment Status : Completed
First Posted : September 24, 2009
Last Update Posted : August 2, 2016
Information provided by (Responsible Party):
Genentech, Inc.